Form 8-K · Item 4.01 · Auditor change
PharmaCyte Biotech, Inc.: auditor change, CBIZ CPAs P.C. to Grassi & Co., CPAs, P.C.
PharmaCyte Biotech, Inc. reported in a Form 8-K filed October 16, 2026, that on October 14, 2026, CBIZ CPAs P.C. was dismissed as its certifying accountant, and Grassi & Co., CPAs, P.C. was engaged. The filing reports no disagreements with the former accountant.
In the filing's words
On October 14, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of PharmaCyte Biotech, Inc. (the “Company”) dismissed CBIZ CPAs P.C. (“CBIZ CPAs”) as the Company’s independent registered public accounting firm, effective as of that date.
there were (i) no “disagreements” (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions thereto) between the Company and CBIZ CPAs on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure
On October 14, 2026, the Audit Committee approved the engagement of Grassi & Co., CPAs, P.C. (“Grassi”) as the Company’s new independent registered public accounting firm, effective as of that date
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | PharmaCyte Biotech, Inc. |
|---|---|
| Ticker | PMCB |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | October 16, 2026 |
| What the filing states | dismissed, engaged |
| Former accountant | CBIZ CPAs P.C. |
| New accountant | Grassi & Co., CPAs, P.C. |
| Date of the change | October 14, 2026 |
| Disagreements | none reported |
| Auditor's letter | Exhibit 16 on sec.gov |
| Accession number | 0001683168-26-007934 |
| SEC CIK | 0001157075 |
PharmaCyte Biotech, Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed October 16, 2026. The filing's own words are quoted above.
Sources
More: all auditor changes · Something wrong? Send a correction with the primary source.